Evidence map›Paper›PMID 39309708›Full record

ArticleOxford medical case reports2024

Phenotypic presentation of

Antonio Mancini, Paola Concolino, Edoardo Vergani, Alessandro Oliva, Giuseppe Macis, Emanuela Traini, Esther Diana Rossi

Abstract readCase Reports
In one paragraph

Article in Oxford medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antonio ManciniOperative Unit of Internal Medicine, Endocrinology and Diabetology, Department of Translational medicine and surgery, Fondazione Policlinico Universitario "Agostino Gemelli", Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Largo Agostino Gemelli, 8, 00168, Rome, Italy.
Paola ConcolinoClinical Chemistry, Biochemistry and Molecular Biology Operations (UOC), Fondazione Policlinico Universitario 'Agostino Gemelli', Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Largo Agostino Gemelli, 8, 00168, Rome, Italy.
Edoardo VerganiOperative Unit of Internal Medicine, Endocrinology and Diabetology, Department of Translational medicine and surgery, Fondazione Policlinico Universitario "Agostino Gemelli", Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Largo Agostino Gemelli, 8, 00168, Rome, Italy.ORCID https://orcid.org/0000-0002-8444-0091
Alessandro OlivaOperative Unit of Internal Medicine, Endocrinology and Diabetology, Department of Translational medicine and surgery, Fondazione Policlinico Universitario "Agostino Gemelli", Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Largo Agostino Gemelli, 8, 00168, Rome, Italy.
Giuseppe MacisDepartment of Diagnostic Imaging, Oncological Radiation Therapy and Hematology Fondazione Policlinico Universitario 'Agostino Gemelli', Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Largo Agostino Gemelli, 8, 00168, Rome, Italy.
Emanuela TrainiEndocrine Surgery Unity, Ospedale San Carlo di Nancy GVM, Via Aurelia, 275, 00165, Rome, Italy.
Esther Diana RossiDivision of Anatomic Pathology and Histology, Catholic University of Sacred Heart, Largo Agostino Gemelli, 8, 00168, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MEN1 is a rare syndrome caused by mutations in the MEN1 gene. We describe a clinical case of MEN1 syndrome associated with a recently discovered pathogenic mutation of MEN1 gene. A 32-year-old man with a history of osteopenia, nephrolithiasis, hypercalcemia and hypophosphatemia, impaired fasting glucose, and asthenia was admitted to our outpatient unit. Primary hyperparathyroidism, sustained by three hyperplastic parathyroid glands, was diagnosed. Prolactin- and GH-secreting adenomas were ruled out. After undergoing subtotal parathyroidectomy, the patient was diagnosed with non-functioning pituitary adenoma, three pancreatic lesions, and Cushing syndrome sustained by left adrenal adenoma. The patient underwent left adrenal surgery; somatostatin analogue lanreotide was started for the pancreatic lesions; the pituitary adenoma, being small and non-secreting, was not treated. A genetic test was performed to confirm the diagnosis of MEN1 syndrome, finding an association with a recently discovered mutation: the (NM_130799.2):c.758delC (p.Ser253Cysfs

Indexed as

geneticshyperparathyroidismMEN1novel mutationspancreatic NETpituitary adenomas

Identifiers

PMID39309708
PMCPMC11416714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.